{"disease":{"id":"transcranial-bone-marrow-injection","name":"transcranial bone marrow injection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07203521","title":"RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":194,"lead_sponsor_name":"Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT07166380","title":"RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Neurodawn Pharmaceutical Co., Ltd.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}